Go to content
UR Home

Plasma Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) as a Possible Biomarker for Severe COVID-19

URN to cite this document:
DOI to cite this document:
Mester, Patricia ; Amend, Pablo ; Schmid, Stephan ; Müller, Martina ; Buechler, Christa ; Pavel, Vlad
[img]License: Creative Commons Attribution 4.0
PDF - Published Version
Date of publication of this fulltext: 24 Jul 2023 15:43


Proprotein convertase subtilisin/kexin type 9 (PCSK9) reduces low density lipoprotein (LDL) uptake, leading to increased plasma levels of LDL. In addition, PCSK9 has been implicated in inflammation independently of the effects on cholesterol metabolism. The current analysis showed that our 156 patients with systemic inflammatory response syndrome (SIRS) or sepsis had higher plasma PCSK9 levels in ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons